Immunovant Inc
Biotechnology
Healthcare
IMVT
171 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
15.71
52 week high
31.44
high
15.78
52 week low
0.00
low
14.86
growth
-49.02 %
previous Close
15.59
P/E ratio
market cap
2.58 B
div yield
0
net incoming
-120.61 M
-13.31 %
net profit margin
-12061300000.00 %
66530.00 %
operating incoming
-127.22 M
-139.23 %
net change in cash
-115.06 M
-133.91 %
cash on hand
599 M
-16.12 %
cost of revenue
107 K
33.75 %
top